Oral presentations
30 September 2011
Sirolimus‐based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta‐analysis
Wenhua Liang, Dongping Wang, Xiaoting Ling, Andrew Allen Kao, Yuan Kong, Yushu Shang, Zhiyong Guo, Xiaoshun He – 30 September 2011 – Sirolimus (SRL) is a novel immunosuppressant with antitumor properties. We performed a meta‐analysis to determine whether SRL can improve patient survival and decrease the risks of tumor recurrence in patients with a pretransplant diagnosis of hepatocellular carcinoma (HCC). We searched databases for controlled clinical trials assessing the survival and oncological benefits of SRL for liver transplant recipients with pretransplant HCC.
Continuing medical education and disclosures
30 September 2011
Category index
30 September 2011
Abstracts
30 September 2011
Table of contents
30 September 2011
JNK: A double‐edged sword in tumorigenesis
Francisco Javier Cubero, Gang Zhao, Christian Trautwein – 28 September 2011
Border patrol intensifies for hepatitis C virus entry
Erin M. McCartney, Nicholas S. Eyre, Michael R. Beard – 28 September 2011
Noninvasive methods for the assessment of liver fibrosis: A window open on the future?
Massimo Pinzani – 28 September 2011
Hepatitis B virus infection: A strong case against ageism
Daniela C. Kroy, Georg M. Lauer – 28 September 2011